Dr. Raghad Karim, MD
Claim this profileNEXT Oncology
Studies Solid Tumors
Studies Pancreatic Cancer
3 reported clinical trials
3 drugs studied
Area of expertise
1Solid Tumors
Stage IV
ER positive
KRAS positive
2Pancreatic Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Raghad Karim, MD is currently running
Zotatifin
for Solid Tumors
This trial is testing a new drug called Zotatifin for patients with advanced cancers that haven't improved with standard treatments. The drug works by stopping cancer cells from making essential proteins, which may slow or stop the cancer.
Recruiting3 awards Phase 1 & 221 criteria
HH2853
for Non-Hodgkin's Lymphoma
This is an open-label, multicenter, first-in-human phase I/II study which is composed of 3 parts: phase I dose escalation, phase I dose extension and phase II. HH2853 will be administered orally on a continuous BID schedule on a continuous 28-day treatment cycle.
Recruiting1 award Phase 1 & 2
More about Raghad Karim, MD
Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Raghad Karim, MD has experience with
- EFT226
- TST001
- HH2853
Breakdown of trials Raghad Karim, MD has run
Pancreatic Cancer
Stomach Cancer
Cancer
Gastroesophageal Junction Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raghad Karim, MD specialize in?
Raghad Karim, MD focuses on Solid Tumors and Pancreatic Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are ER positive.
Is Raghad Karim, MD currently recruiting for clinical trials?
Yes, Raghad Karim, MD is currently recruiting for 2 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Raghad Karim, MD has studied deeply?
Yes, Raghad Karim, MD has studied treatments such as eFT226, TST001, HH2853.
What is the best way to schedule an appointment with Raghad Karim, MD?
Apply for one of the trials that Raghad Karim, MD is conducting.
What is the office address of Raghad Karim, MD?
The office of Raghad Karim, MD is located at: NEXT Oncology, San Antonio, Texas 78229 United States. This is the address for their practice at the NEXT Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.